The extent of similarity in clinical speech disorder and underlying cognitive impairments between ZDHHC9, FOXP2, and other monogenic disorders of language development is not yet known and should be the focus of a future comparative study ideally in parallel with longitudinal comparative neuroimaging. The gene discussed is FOXP2; the disease is speech disorder.